Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to echinocandins in Candida glabrata

Journal of Clinical Microbiology

Volumn 52, Issue 3, 2014, Pages 790-795

  Pham, Cau D ^a   Bolden, Carol B ^a   Kuykendall, Randall J ^a   Lockhart, Shawn R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHINOCANDIN; MICROSPHERE;

ANTIFUNGAL RESISTANCE; ARTICLE; BACTERIUM EXAMINATION; CANDIDA GLABRATA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; FKS1 GENE; FKS2 GENE; FUNGAL GENE; FUNGUS IDENTIFICATION; FUNGUS MUTATION; GENE STRUCTURE; HIGH THROUGHPUT SCREENING; HS1 GENE; IN VITRO STUDY; LUMINEX BASED MULTIPLEX ASSAY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RAPID TEST; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

CANDIDA GLABRATA; COST-BENEFIT ANALYSIS; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; GENES, FUNGAL; GLUCOSYLTRANSFERASES; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; TIME;

EID: 84894520840     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03378-13     Document Type: Article

References (23)

1. Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden C, Baughman W, Stein B, Hollick R, Park B, Chiller T. 2012. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance in two US cities: 2008-2011. J. Clin. Microbiol. 50:3435-3442. http://dx.doi.org/10.1128/JCM.01283-12.
2. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. 2011. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J. Clin. Microbiol. 49:396-399. http://dx.doi.org/10.1128/AAC.00570-11.
3. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of America. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535. http://dx.doi.org/10.1086/596757.
4. Pfaller MA, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Kroeger J, Diekema DJ. 2009. Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J. Clin. Microbiol. 47:3185-3190. http://dx.doi.org/10.1128/JCM.02437-10.
5. Lee I, Fishman NO, Zaoutis TE, Morales KH, Weiner MG, Synnestvedt M, Nachamkin I, Lautenbach E. 2009. Risk factors for fluconazoleresistant Candida glabrata bloodstream infections. Arch. Intern. Med. 169:379-383. http://dx.doi.org/10.1001/archinte.169.4.379.
6. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. 2012. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J. Clin. Microbiol. 50:1199-1203. http://dx.doi.org/10.1128/JCM.06112-11.
7. Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS. 2008. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob. Agents Chemother. 52:2263-2265. http://dx.doi.org/10.1128/AAC.01568-07. (Pubitemid 351758575)
8. Zimbeck AJ, Iqbal N, Ahlquist AM, Farley MM, Harrison LH, Chiller T, Lockhart SR. 2010. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based sur-veillance. Antimicrob. Agents Chemother. 54:5042-5047. http://dx.doi.org/10.1128/AAC.00836-10.
9. Shields RK, Nguyen MH, Press EG, Kwa AL, Cheng S, Du C, Clancy CJ. 2012. The presence of an FKS mutation rather thanMICis an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob. Agents Chemother. 56:4862-4869. http://dx.doi.org/10.1128/AAC.00027-12.
10. Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. 2013. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin. Infect. Dis. 56:1724-1732. http://dx.doi.org/10.1093/cid/cit136.
11. Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E, Li W, Vyas V, Fan H, Abruzzo G, Flattery A, Gill C, Chrebet G, Parent SA, Kurtz M, Teppler H, Douglas CM, Perlin DS. 2005. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates. Antimicrob. Agents Chemother. 49:3264-3273. http://dx.doi.org/10. 1128/AAC.49.8.3264-3273.2005. (Pubitemid 41060570)
12. Katiyar SK, Alastruey-Izquierdo A, Healey KR, Johnson ME, Perlin DS, Edlind TD. 2012. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance. Antimicrob. Agents Chemother. 56:6304-6309. http://dx.doi.org/10.1128/AAC.00813- 12.
13. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS. 2009. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob. Agents Chemother. 53:3690-3699. http://dx.doi.org/10.1128/AAC.00443-09.
14. Garcia-Effron G, Chua DJ, Tomada JR, Dipersio J, Perlin DS, Ghannoum M, Bonilla H. 2010. Novel FKS mutations associated with echinocandin resistance in Candida species. Antimicrob. Agents Chemother. 54: 2225-2227. http://dx.doi.org/10.1128/AAC.00998-09.
15. Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD. 2010. Breakthrough invasive candidiasis in patients on micafungin. J. Clin. Microbiol. 48:2373-2380. http://dx.doi.org/10.1128/JCM.02390-09.
16. Bovers M, Diaz MR, Hagen F, Spanjaard L, Duim B, Visser CE, Hoogveld HL, Scharringa J, Hoepelman IM, Fell JW, Boekhout T. 2007. Identification of genotypically diverse Cryptococcus neoformans and Cryptococcus gattii isolates by Luminex xMAP technology. J. Clin. Microbiol. 45:1874-1883. http://dx.doi.org/10.1128/JCM.02390-09. (Pubitemid 46933920)
17. Etienne KA, Kano R, Balajee SA. 2009. Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli. J. Clin. Microbiol. 47:1096-1100. http://dx.doi.org/10.1128/JCM. 01899-08.
18. Deak E, Etienne KA, Lockhart SR, Gade L, Chiller T, Balajee SA. 2010. Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance. Can. J.Microbiol. 56:348-351. http://dx.doi.org/10.1139/w10-003.
19. Babady NE, Miranda E, Gilhuley KA. 2011. Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. J. Clin. Microbiol. 49:3777-3782. http://dx.doi.org/10.1128/JCM.01135- 11.
20. Balada-Llasat JM, LaRue H, Kamboj K, Rigali L, Smith D, Thomas K, Pancholi P. 2012. Detection of yeasts in blood cultures by the Luminex xTAG fungal assay. J. Clin. Microbiol. 50:492-494. http://dx.doi.org/10.1128/JCM. 06375-11.
21. Bando H, Yoshino T, Shinozaki E, Nishina T, Yamazaki K, Yamaguchi K, Yuki S, Kajiura S, Fujii S, Yamanaka T, Tsuchihara K, Ohtsu A. 2013. Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit. BMC Cancer 13:405. http://dx.doi.org/10.1186/1471-2407-13-405.
22. Thierry S, Hamidjaja RA, Girault G, Löfström C, Ruuls R, Sylviane D. 2013. A multiplex bead-based suspension array assay for interrogation of phylogenetically informative single nucleotide polymorphisms for Bacillus anthracis. J. Microbiol. Methods 95:357-365. http://dx.doi.org/10. 1016/j.mimet.2013.10.004.
23. Cleveland AA, Farley MM, Harrison LH, Lockhart SR, Magill SS, Chiller TM, Park BJ. 2012. Changes in epidemiology of candidemia and antifungal drug resistance in two U.S. locations: results from a population-based active laboratory surveillance, 2008-2010. Clin. Infect. Dis. 55:1352-1361. http://dx.doi.org/10.1093/cid/cis697.